Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Current Assets: 2009-2024

Historic Current Assets for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $3.9 billion.

  • UNITED THERAPEUTICS's Current Assets fell 12.66% to $3.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 12.66%. This contributed to the annual value of $3.9 billion for FY2024, which is 9.09% up from last year.
  • According to the latest figures from FY2024, UNITED THERAPEUTICS's Current Assets is $3.9 billion, which was up 9.09% from $3.6 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Current Assets ranged from a high of $3.9 billion in FY2024 and a low of $2.2 billion during FY2020.
  • Moreover, its 3-year median value for Current Assets was $3.6 billion (2023), whereas its average is $3.6 billion.
  • Data for UNITED THERAPEUTICS's Current Assets shows a peak YoY spiked of 45.48% (in 2022) over the last 5 years.
  • Over the past 5 years, UNITED THERAPEUTICS's Current Assets (Yearly) stood at $2.2 billion in 2020, then increased by 7.22% to $2.3 billion in 2021, then surged by 45.48% to $3.4 billion in 2022, then climbed by 5.05% to $3.6 billion in 2023, then increased by 9.09% to $3.9 billion in 2024.